|
1）Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006; 130: 1466-79
|
|
|
|
|
2）Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006; 130: 1480-91
|
|
|
|
|
|
3）Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology. 1990; 99: 409-15
|
|
|
|
|
|
4）Ananthakrishnan AN, McGinley EL, Saeian K. Length of office visits for gastrointestinal disease: impact of physician specialty. Am J Gastroenterol. 2010; 105: 1719-25
|
|
|
|
|
5）Ford AC, Marwaha A, Lim A, et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010; 8: 401-9
|
|
|
|
|
|
6）Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002; 123: 2108-31
|
|
|
|
|
|
7）Saito YA, Schoenfeld P, Locke III GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002; 97: 1910-5
|
|
|
|
|
|
8）Kumano H, Kaiya H, Yoshiuchi K, et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol. 2004; 99: 370-6
|
|
|
|
|
|
9）Garakani A, Win T, Virk S, et al. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. Am J Ther. 2003; 10: 61-7
|
|
|
|
|
|
10）Tanaka Y, Kanazawa M, Fukudo S, et al. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011; 17: 131-9
|
|
|
|
|
|
11）Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007; 132: 397-414
|
|
|
|
|
|
12）Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998; 42: 845-9
|
|
|
|
|
|
13）Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011; 12: 453-66
|
|
|
|
|
|
14）Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007; 55: 377-91
|
|
|
|
|
|
15）Wilder-Smith CH. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders. Gut. 2011; 60: 1589-99
|
|
|
|
|
|
16）Mayer EA, Tillisch K, Ellingson BM. Dyspepsia: Structural changes in functional gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2013; 10: 200-2
|
|
|
|
|
|
17）Van Oudenhove L, Coen SJ, Aziz Q. Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol. 2007; 13: 3438-45
|
|
|
|
|
|
18）Hong JY, Kilpatrick LA, Labus JS, et al. Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain. J Neurosci. 2014; 34: 14252-9
|
|
|
|
|
|
19）Niddam DM, Tsai SY, Lu CL, et al. Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome: preliminary findings using magnetic resonance spectroscopy. Am J Gastroenterol. 2011; 106: 1503-11
|
|
|
|
|
|
20）Aizawa E, Sato Y, Kochiyama T, et al. Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling. Gastroenterology. 2012; 143: 1188-98
|
|
|
|
|
|
21）Lorena SL, Figueiredo MJ, Almeida JR, et al. Autonomic function in patients with functional dyspepsia assessed by 24-hour heart rate variability. Dig Dis Sci. 2002; 47: 27-31
|
|
|
|
|
|
22）Mazurak N, Seredyuk N, Sauer H, et al. Heart rate variability in the irritable bowel syndrome: a review of the literature. Neurogastroenterol Motil. 2012; 24: 206-16
|
|
|
|
|
|
23）De Giorgi F, Sarnelli G, Cirillo C, et al. Increased severity of dyspeptic symptoms related to mental stress is associated with sympathetic hyperactivity and enhanced endocrine response in patients with postprandial distress syndrome. Neurogastroenterol Motil. 2013; 25: 31-8. e2-3
|
|
|
|
|
|
24）Fukudo S, Saito K, Sagami Y, et al. Can modulating corticotropin releasing hormone receptors alter visceral sensitivity? Gut. 2006; 55: 146-8
|
|
|
|
|
|
25）Tayama J, Sagami Y, Shimada Y, et al. Effect of alpha-helical CRH on quantitative electroencephalogram in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2007; 19: 471-83
|
|
|
|
|
|
26）Sagami Y, Shimada Y, Tayama J, et al. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut. 2004; 53: 958-64
|
|
|
|
|
|
27）Su J, Tanaka Y, Muratsubaki T, et al. Injection of corticotropin-releasing hormone into the amygdala aggravates visceral nociception and induces noradrenaline release in rats. Neurogastroenterol Motil. 2014 Oct 31. [Epub ahead of print]
|
|
|
|
|
|
28）Labus JS, Hubbard CS, Bueller J, et al. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome. Gastroenterology. 2013; 145: 1253-61
|
|
|
|
|